These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3321101)

  • 41. The endogenous opioid system: a common substrate in drug addiction.
    Trigo JM; Martin-García E; Berrendero F; Robledo P; Maldonado R
    Drug Alcohol Depend; 2010 May; 108(3):183-94. PubMed ID: 19945803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder.
    Edwards S
    Prog Brain Res; 2016; 223():63-76. PubMed ID: 26806771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid and nondopamine reward circuitry and state-dependent mechanisms.
    Fujita M; Ide S; Ikeda K
    Ann N Y Acad Sci; 2019 Sep; 1451(1):29-41. PubMed ID: 29512887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid modulation of taste hedonics within the ventral striatum.
    Kelley AE; Bakshi VP; Haber SN; Steininger TL; Will MJ; Zhang M
    Physiol Behav; 2002 Jul; 76(3):365-77. PubMed ID: 12117573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries.
    Wscieklica T; de Barros Viana M; Le Sueur Maluf L; Pouza KC; Spadari RC; Céspedes IC
    Alcohol; 2016 Feb; 50():73-82. PubMed ID: 26786746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.
    Blum K; Liu Y; Wang W; Wang Y; Zhang Y; Oscar-Berman M; Smolen A; Febo M; Han D; Simpatico T; Cronjé FJ; Demetrovics Z; Gold MS
    Postgrad Med; 2015 Mar; 127(2):232-41. PubMed ID: 25526228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core.
    Kelley AE; Smith-Roe SL; Holahan MR
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12174-9. PubMed ID: 9342382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine and endogenous opioids: neurochemical and pharmacological evidence.
    Hadjiconstantinou M; Neff NH
    Neuropharmacology; 2011 Jun; 60(7-8):1209-20. PubMed ID: 21108953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine.
    Salamone JD; Correa M
    Behav Brain Res; 2002 Dec; 137(1-2):3-25. PubMed ID: 12445713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid modulation of ventral pallidal inputs.
    Napier TC; Mitrovic I
    Ann N Y Acad Sci; 1999 Jun; 877():176-201. PubMed ID: 10415650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoid transmission and reward-related events.
    Gardner EL; Vorel SR
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):502-33. PubMed ID: 9974181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of Pedunculopontine Glutamate Neurons Is Reinforcing.
    Yoo JH; Zell V; Wu J; Punta C; Ramajayam N; Shen X; Faget L; Lilascharoen V; Lim BK; Hnasko TS
    J Neurosci; 2017 Jan; 37(1):38-46. PubMed ID: 28053028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields.
    Wise RA; McDevitt RA
    Neuropsychopharmacology; 2018 Mar; 43(4):680-689. PubMed ID: 28984293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward.
    Jerlhag E; Egecioglu E; Dickson SL; Andersson M; Svensson L; Engel JA
    Addict Biol; 2006 Mar; 11(1):45-54. PubMed ID: 16759336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reward circuitry dopaminergic activation regulates food and drug craving behavior.
    Blum K; Liu Y; Shriner R; Gold MS
    Curr Pharm Des; 2011; 17(12):1158-67. PubMed ID: 21492092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between glucocorticoid hormones, stress and psychostimulant drugs.
    Marinelli M; Piazza PV
    Eur J Neurosci; 2002 Aug; 16(3):387-94. PubMed ID: 12193179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The physiology of opiate hedonic effects and the role of opioids in motivated behavior.
    Carr KD
    Adv Alcohol Subst Abuse; 1984; 3(3):5-18. PubMed ID: 6388274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.